Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
May activate transcription. Additionally we are shipping PTOV1 Proteins (6) and many more products for this protein.
Showing 10 out of 45 products:
Human Polyclonal PTOV1 Primary Antibody for EIA, IHC (p) - ABIN954371
Morote, Fernández, Alaña, Iglesias, Planas, Reventós, Ramón Y Cajal, Paciucci, de Torres: PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. in Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Show all 5 references for 954371
Cow (Bovine) Polyclonal PTOV1 Primary Antibody for IHC, WB - ABIN2784251
Santamaría, Castellanos, Gómez, Benedit, Renau-Piqueras, Morote, Reventós, Thomson, Paciucci: PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. in Molecular and cellular biology 2005
Show all 2 references for 2784251
Human Polyclonal PTOV1 Primary Antibody for ICC, IF - ABIN4348560
Lei, Zhang, Li, Lin, Wu, Li, Liu: Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer. in BMC cancer 2014
Show all 2 references for 4348560
PTOV1 is associated with UCH-L1 (show UCHL1 Antibodies) and in response to estrogen stimuli during the mouse oocyte development
Studies indicate that the number of binding partners and associated cellular functions has increased and helped to identify prostate-tumor-overexpressed-1 (PTOV1) as regulator of gene expression at transcription and translation levels.
this study takes the lead to demonstrate that the overexpressed PTOV1 plays a vital role in the tumorigenesis and progression of esophageal squamous cell carcinoma, and it is potentially a valuable prognostic predicator and new chemotherapeutic target for esophageal squamous cell carcinoma
All the study samples showed a considerable decrease in PTOV1 expression in prostate cancer and HGPIN compared to morphologically normal glands.
High PTOV1 expression was associated with invasive urothelial carcinoma.
PTOV1 overexpression is associated with poor survival outcomes of nasopharyngeal carcinoma patients.
PTOV1 protein abnormal expression might contribute to the malignant progression of epithelial ovarian cancer.
Our study demonstrated that PTOV1 overexpression is correlated with increased aggressiveness of hepatocellular carcinoma and could be a prognostic biomarker for patients with HCC (show FAM126A Antibodies)
The study showed that PTOV1 is upregulated in breast cancer cell lines and clinical samples, and its expression was positively associated with progression and aggressiveness of breast cancer, suggesting that PTOV1 could serve as an independent prognostic marker.
In prostate tumors, the overexpression of PTOV1 was associated with decreased expression of HEY1 and HES1, and this correlation was significant in metastatic lesions.
RA-induced cancer cell cytotoxicity was significantly impaired by Zyxin (show ZYX Antibodies) or PTOV1. Overall, our findings suggest that Zyxin (show ZYX Antibodies) and PTOV1 should be considered as critical determinants in cancer therapy with retinoids
May activate transcription. Required for nuclear translocation of FLOT1. Promotes cell proliferation (By similarity).
granule cell antiserum positive 3
, prostate tumor-overexpressed gene 1 protein homolog
, activator interaction domain-containing protein 2
, prostate tumor overexpressed gene 1
, prostate tumor-overexpressed gene 1 protein
, prostate tumor over expressed gene 1